Mental Health
News from the FDA/CDC
Anxiety and depression widespread among arthritis patients
Anxiety is far more common, but depression is more likely to be treated.
Conference Coverage
Promising novel antidepressant cruising in pipeline
BARCELONA – “This is a compound with a very, very rich pharmacology – so rich that we don’t know exactly which of the pharmacologic effects are...
From the Journals
Teens who vape are likely to add cigarette smoking
Vaping by teens often leads to adding cigarettes and possibly alcohol and marijuana use.
Conference Coverage
Sexual assault and harassment linked to hypertension, depression, and anxiety
Women may lack the financial stability to leave abusive work situations.
Conference Coverage
Previous psychiatric admissions predict suicide attempts
SAN DIEGO – A past history of suicide attempts did not emerge as one of the top 10 influential predictors.
Latest News
Eat, toke or vape: Teens not too picky when it comes to pot’s potpourri
“We are concerned about the developing teen brain, the potential effects on cognitive development, mood and exposure to cannabinoids and chemicals...
Behavioral Health
How to treat complicated grief
Several DSM-5 criteria lasting 6 months or longer can help identify complicated grief, as can available assessment tools. Treatment has a...
Conference Coverage
Mental health visits, boarding continue to climb
ED length of stay for patients requiring inpatient care are also increasing.
From the Journals
Behavioral checklist IDs children at risk of depressive, anxiety disorders
The highest risk was among children with a parental history of mood disorder and baseline CBCL anxiety/depression subsyndromal elevations.
News
Emgality approved for migraine prevention in adults
The calcitonin gene–related peptide antagonist was tested in both episodic and chronic migraine.
Latest News
House, Senate agree on broad opioid legislation
Huge bill to address the opioid epidemic contains many provisions that will affect physicians.